Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Seroconversion after anti-SARS-CoV-2 mRNA vaccinations among moderate-to-severe psoriatic patients receiving systemic biologicals-Prospective observational cohort study.
Piros ÉA, Cseprekál O, Görög A, Hidvégi B, Medvecz M, Szabó Z, Olajos F, Barabás E, Galajda N, Miheller P, Holló P. Piros ÉA, et al. Among authors: miheller p. Dermatol Ther. 2022 May;35(5):e15408. doi: 10.1111/dth.15408. Epub 2022 Mar 5. Dermatol Ther. 2022. PMID: 35218276 Free PMC article.
Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy.
Bálint A, Farkas K, Éva PK, Terhes G, Urbán E, Szucs M, Nyári T, Bata Z, Nagy F, Szepes Z, Miheller P, Lorinczy K, Lakatos PL, Lovász B, Tamás S, Kulcsár A, Berényi A, Törocsik D, Daróczi T, Saródi Z, Wittmann T, Molnár T. Bálint A, et al. Among authors: miheller p. Scand J Gastroenterol. 2015 Feb;50(2):174-81. doi: 10.3109/00365521.2014.928902. Epub 2014 Nov 11. Scand J Gastroenterol. 2015. PMID: 25384624 Clinical Trial.
Clinical efficacy, drug sustainability and serum drug levels in Crohn's disease patients treated with ustekinumab - A prospective, multicenter cohort from Hungary.
Gonczi L, Szanto K, Farkas K, Molnar T, Szamosi T, Schafer E, Golovics PA, Barkai L, Lontai L, Lovasz B, Juhasz M, Patai A, Sarang K, Vincze A, Sarlos P, Farkas A, Dubravcsik Z, Toth TG, Miheller P, Ilias A, Lakatos PL. Gonczi L, et al. Among authors: miheller p. Dig Liver Dis. 2022 Feb;54(2):207-213. doi: 10.1016/j.dld.2021.07.008. Epub 2021 Jul 31. Dig Liver Dis. 2022. PMID: 34344576
Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study.
Bacsur P, Matuz M, Resál T, Miheller P, Szamosi T, Schäfer E, Sarlós P, Iliás Á, Szántó K, Rutka M, Bálint A, Milassin Á, Fábián A, Bor R, Szepes Z, Molnár T, Farkas K. Bacsur P, et al. Among authors: miheller p. Therap Adv Gastroenterol. 2022 Dec 26;15:17562848221144349. doi: 10.1177/17562848221144349. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 36600684 Free PMC article.
Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination.
Resál T, Bacsur P, Horváth M, Szántó K, Rutka M, Bálint A, Fábián A, Bor R, Szepes Z, Fekete J, Farkas K, Miheller P, Molnár T. Resál T, et al. Among authors: miheller p. Therap Adv Gastroenterol. 2023 Jul 14;16:17562848231183529. doi: 10.1177/17562848231183529. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37461738 Free PMC article.
117 results